KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Common Equity (2016 - 2025)

Historic Common Equity for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $51.0 billion.

  • Thermo Fisher Scientific's Common Equity rose 419.01% to $51.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $51.0 billion, marking a year-over-year increase of 419.01%. This contributed to the annual value of $49.6 billion for FY2024, which is 609.61% up from last year.
  • Thermo Fisher Scientific's Common Equity amounted to $51.0 billion in Q3 2025, which was up 419.01% from $50.5 billion recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Common Equity ranged from a high of $51.0 billion in Q3 2025 and a low of $35.1 billion during Q2 2021
  • Over the past 5 years, Thermo Fisher Scientific's median Common Equity value was $44.0 billion (recorded in 2022), while the average stood at $44.4 billion.
  • As far as peak fluctuations go, Thermo Fisher Scientific's Common Equity soared by 2336.07% in 2021, and later skyrocketed by 314.98% in 2023.
  • Over the past 5 years, Thermo Fisher Scientific's Common Equity (Quarter) stood at $40.9 billion in 2021, then rose by 7.78% to $44.0 billion in 2022, then increased by 6.14% to $46.7 billion in 2023, then rose by 6.1% to $49.6 billion in 2024, then grew by 2.9% to $51.0 billion in 2025.
  • Its last three reported values are $51.0 billion in Q3 2025, $50.5 billion for Q2 2025, and $49.4 billion during Q1 2025.